Family Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.13M Sell
4,066
-138
-3% -$72.5K 0.32% 72
2025
Q1
$2.67M Buy
4,204
+80
+2% +$50.7K 0.44% 60
2024
Q4
$2.94M Buy
4,124
+124
+3% +$88.3K 0.47% 51
2024
Q3
$4.2M Sell
4,000
-2,650
-40% -$2.79M 0.69% 36
2024
Q2
$6.99M Buy
6,650
+374
+6% +$393K 1.23% 19
2024
Q1
$6.04M Buy
6,276
+577
+10% +$555K 1.11% 22
2023
Q4
$5.01M Sell
5,699
-443
-7% -$389K 1.04% 25
2023
Q3
$5.05M Sell
6,142
-63
-1% -$51.8K 1.15% 23
2023
Q2
$4.46M Sell
6,205
-86
-1% -$61.8K 0.98% 26
2023
Q1
$5.17M Buy
6,291
+320
+5% +$263K 1.19% 25
2022
Q4
$4.31M Sell
5,971
-65
-1% -$46.9K 1.05% 28
2022
Q3
$4.16M Sell
6,036
-66
-1% -$45.5K 1.07% 23
2022
Q2
$3.61M Sell
6,102
-269
-4% -$159K 0.97% 28
2022
Q1
$4.45M Sell
6,371
-13
-0.2% -$9.08K 1.23% 23
2021
Q4
$4.03M Buy
6,384
+119
+2% +$75.2K 1.05% 31
2021
Q3
$3.79M Buy
6,265
+61
+1% +$36.9K 1.05% 31
2021
Q2
$3.47M Sell
6,204
-882
-12% -$493K 0.92% 34
2021
Q1
$3.35M Buy
7,086
+63
+0.9% +$29.8K 1.05% 31
2020
Q4
$3.39M Buy
7,023
+1,796
+34% +$868K 1.16% 31
2020
Q3
$2.93M Sell
5,227
-1,457
-22% -$816K 1.28% 26
2020
Q2
$4.17M Sell
6,684
-1,920
-22% -$1.2M 1.7% 15
2020
Q1
$4.2M Sell
8,604
-112
-1% -$54.7K 2.1% 10
2019
Q4
$3.27M Sell
8,716
-14
-0.2% -$5.26K 1.13% 29
2019
Q3
$2.42M Sell
8,730
-7
-0.1% -$1.94K 0.9% 35
2019
Q2
$2.74M Buy
8,737
+134
+2% +$41.9K 1.07% 31
2019
Q1
$3.53M Buy
8,603
+4,087
+91% +$1.68M 1.52% 15
2018
Q4
$1.69M Buy
+4,516
New +$1.69M 0.71% 42